In 1994, the American Sleep Disorders Association

Similar documents
Development of a portable device for home monitoring of. snoring. Abstract

S. Esnaola*, J. Durán**, C. Infante-Rivard +, R. Rubio**, A. Fernández +

The Latest Technology from CareFusion

Arousal detection in sleep

Web-Based Home Sleep Testing

Obstructive sleep apnoea How to identify?

DECLARATION OF CONFLICT OF INTEREST

Cerebral Anoxic Attacks in Sleep Apnea Syndrome

Influence of setting on unattended respiratory monitoring in the sleep apnoea/hypopnoea syndrome

Traffic Accidents in Commercial Long-Haul Truck Drivers: The Influence of Sleep-Disordered Breathing and Obesity

Portable Computerized Polysomnography in Attended and Unattended Settings*

CYCLICAL NOCTURNAL OXYGEN DESATURATION AND IMPACT ON ACTIVITIES OF DAILY LIVING IN ELDERLY PATIENTS

Automated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea

Prediction of sleep-disordered breathing by unattended overnight oximetry

In-Patient Sleep Testing/Management Boaz Markewitz, MD

Hand-scoring of MESAM 4 recordings is more accurate than automatic analysis in screening for obstructive sleep apnoea

Nasal pressure recording in the diagnosis of sleep apnoea hypopnoea syndrome

Methods of Diagnosing Sleep Apnea. The Diagnosis of Sleep Apnea: Questionnaires and Home Studies

José Haba-Rubio, MD; Jean-Paul Janssens, MD; Thierry Rochat, MD, PhD; and Emilia Sforza, MD, PhD

SLEEP DISORDERED BREATHING The Clinical Conditions

Assessment of a wrist-worn device in the detection of obstructive sleep apnea

Practice Parameters for the Use of Portable Monitoring Devices in the Investigation of Suspected Obstructive Sleep Apnea in Adults

O bstructive sleep apnoea-hypopnoea (OSAH) is a highly

PREDICTIVE VALUE OF AUTOMATED OXYGEN SATURATION ANALYSIS FOR THE DIAGNOSIS AND TREATMENT OF OBSTRUCTIVE SLEEP APNEA IN A HOME-BASED SETTING

Pulse Oximetry Test: Summary Report

Introducing the WatchPAT 200 # 1 Home Sleep Study Device

CPAP titration by an auto-cpap device based on snoring detection: a clinical trial and economic considerations

The amount of nightly variability that occurs in sleepdisordered. Nightly variability of sleep-disordered breathing measured over 3 nights

Key words: adenotonsillectomy; arousal; rapid eye movement sleep; sleep apnea

The use of overnight pulse oximetry for obstructive sleep apnoea in a resource poor setting in Sri Lanka

(To be filled by the treating physician)

Challenging Cases in Pediatric Polysomnography. Fauziya Hassan, MBBS, MS Assistant Professor Pediatric Pulmonary and Sleep

Polysomnography (PSG) (Sleep Studies), Sleep Center

Simple diagnostic tools for the Screening of Sleep Apnea in subjects with high risk of cardiovascular disease

Up to 50% of continuous flow oxygen therapy patients experience clinically significant nocturnal desaturation. 1

OSA and COPD: What happens when the two OVERLAP?

Suitability of New Methods for Pulseoximetric Data Analysis in Screening Diagnostics of Respiratory Disorders During Sleep (RDDS)

PEDIATRIC SLEEP GUIDELINES Version 1.0; Effective

Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea

ASDA Standards of Practice. Portable Recording in the Assessment of Obstructive Sleep Apnea

Normative data on snoring: a comparison between younger and older adults

The Effect of Altitude Descent on Obstructive Sleep Apnea*

Non-contact Screening System with Two Microwave Radars in the Diagnosis of Sleep Apnea-Hypopnea Syndrome

BiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT

Evaluation of a 2-Channel Portable Device and a Predictive Model to Screen for Obstructive Sleep Apnea in a Laboratory Environment

Index SLEEP MEDICINE CLINICS. Note: Page numbers of article titles are in boldface type.

The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome

Obstructive sleep apnea (OSA) is characterized by. Quality of Life in Patients with Obstructive Sleep Apnea*

Diabetes & Obstructive Sleep Apnoea risk. Jaynie Pateraki MSc RGN

Sleep and the Heart Reversing the Effects of Sleep Apnea to Better Manage Heart Disease

The Familial Occurrence of Obstructive Sleep Apnoea Syndrome (OSAS)

Sleep Studies: Attended Polysomnography and Portable Polysomnography Tests, Multiple Sleep Latency Testing and Maintenance of Wakefulness Testing

Berlin Questionnaire and Portable Monitoring Device for Diagnosing Obstructive Sleep Apnea: A Preliminary Study in Jakarta, Indonesia

Effectiveness of Portable Monitoring Devices for Diagnosing Obstructive Sleep Apnea: Update of a Systematic Review

International Journal of Scientific & Engineering Research Volume 9, Issue 1, January ISSN

BTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012

Valerie G. Kirk, MD, FCCP; Shelly G. Bohn, BSc; W. Ward Flemons, MD; and John E. Remmers, MD

A Deadly Combination: Central Sleep Apnea & Heart Failure

Key words: Medicare; obstructive sleep apnea; oximetry; sleep apnea syndromes

The Effect of a Mandibular Advancement Device on Apneas and Sleep in Patients With Obstructive Sleep Apnea*

Pulse Rate Variability Analysis to Enhance Oximetry as at-home Alternative for Sleep Apnea Diagnosing

EFFICACY OF MODAFINIL IN 10 TAIWANESE PATIENTS WITH NARCOLEPSY: FINDINGS USING THE MULTIPLE SLEEP LATENCY TEST AND EPWORTH SLEEPINESS SCALE

18/06/2009 NZ Respiratory & Sleep Institute

Respiratory Event Detection by a Positive Airway Pressure Device

Pain Module. Opioid-RelatedRespiratory Depression (ORRD)

POLICY All patients will be assessed for risk factors associated with OSA prior to any surgical procedures.

Obstructive Sleep Apnea

PORTABLE OR HOME SLEEP STUDIES FOR ADULT PATIENTS:

Coding for Sleep Disorders Jennifer Rose V. Molano, MD

OSA - Obstructive sleep apnoea What you need to know if you think you might have OSA

Quantification of sleep disordered breathing by computerized analysis of oximetry, heart rate and snoring

New Government O2 Criteria and Expert Panel. Jennifer Despain, RPSGT, RST, AS

Interdisciplinary Care of the Patient with Amyotrophic Lateral Sclerosis Respiratory Therapy Care

Obstructive Sleep Apnea Severity Multiclass Classification Using Analysis of Snoring Sounds

The Ignored Parameter in the Diagnosis of Obstructive Sleep Apnea Syndrome: The Oxygen Desaturation Index

11/20/2015. Eighth Biennial Pediatric Sleep Medicine Conference. November 12-15, 2015 Omni Amelia Island Plantation Resort Amelia Island, Florida

Split Night Protocols for Adult Patients - Updated July 2012

Triennial Pulmonary Workshop 2012

Policy Specific Section: October 1, 2010 January 21, 2013

SleepView. SleepView. Monitor + SleepViewSM. Portal Clinical Validation Summary. CliniCal validation

FAQ CODING & REIMBURSEMENT. WatchPAT TM Home Sleep Test

PVDOMICS. Sleep Core. Cleveland Clinic Cleveland, Ohio

Stellar 100 Stellar 150

Image: Scott Leight, istockphoto

sleepview by midmark Home Sleep Test

The recommended method for diagnosing sleep

Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome

Short-term effects of a vibrotactile neck-based treatment device for positional obstructive sleep apnea: preliminary data on tolerability and efficacy

Appendix D An unresponsive patient with shallow, gasping breaths at a rate of six per minute requires:

ONLINE DATA SUPPLEMENT. Impact of Obstructive Sleep Apnea on Left Ventricular Mass and. Diastolic Function

Y. Sivan*, A. Kornecki*, T. Schonfeld**

Types of Sleep Studies 8/28/2018. Ronald S. Prehn, ThM, DDS. Type 1 Attended in-lab polysomnography (PSG) 18 leads

SOMNOcheck micro CARDIO. Simple Assessment of Cardiovascular Risk During Sleep. In sleep medicine In internal medicine In preventive medicine

General Outline. General Outline. Pathogenesis of Metabolic Dysfunction in Sleep Apnea: The Role of Sleep Fragmentation and Intermittent Hypoxemia

Auto Servo Ventilation Indications, Basics of Algorithm, and Titration

CHANGING SHAPE OF SLEEP STUDIES

ALCO Regulations. Protocol pg. 47

Transcription:

Unreliability of Automatic Scoring of MESAM 4 in Assessing Patients With Complicated Obstructive Sleep Apnea Syndrome* Fabio Cirignotta, MD; Susanna Mondini, MD; Roberto Gerardi, MD Barbara Mostacci, MD; and Elisa Sancisi, MD Background: Portable devices are used for unattended recording of patients with suspected obstructive sleep apnea syndrome (OSAS). The MESAM 4 (MAP; Martinsried, Germany) is a computerized ambulatory polysomnographic system that records four parameters: breathing noise, heart rate, arterial oxygen saturation (SaO 2 ), and body position. Design and method: We evaluated the reliability of the oxygen desaturation index (ODI) automatically calculated by the MESAM 4 device in evaluating patients with complicated OSAS. These patients present SaO 2 drops due to apneas associated with a fall in baseline SaO 2 during sleep, as occurs in the overlap syndrome. Ten patients with complicated OSAS underwent nocturnal MESAM 4 recordings, and we compared the visual and automatic scorings of the ODI. Results: The ODI obtained with visual scoring was significantly higher than ODI automatically calculated by the MESAM 4 in all patients. In some patients, this difference was so significant that it could bias clinical judgment of OSAS severity. We demonstrated that the system did not identify those desaturation events that were superimposed on a fall in baseline SaO 2. The error depends on the algorithm by which the device recognizes the desaturation events and calculates the baseline SaO 2. Conclusion: Automatic analysis of MESAM 4 recordings may be misleading in evaluating OSAS patients who have a fall in baseline SaO 2 during sleep. In this case, visual scoring performed by a trained polysomnographer is recommended. (CHEST 2001; 119:1387 1392) Key words: cardiorespiratory monitoring; MESAM 4; sleep apnea Abbreviations: ASDA American Sleep Disorders Association; ODI oxygen desaturation index; OSAS obstructive sleep apnea syndrome; RDI respiratory disorder index; Sao 2 arterial oxygen saturation In 1994, the American Sleep Disorders Association (ASDA) identified four levels of recordings for the assessment of obstructive sleep apnea syndrome (OSAS). 1 Level I or standard polysomnography is the For editorial comment see page 1303 attended in-laboratory recording of standard sleep and respiratory variables. Level II or comprehensive portable polysomnography is the unattended off-site *From the Sleep Medicine Unit, Unit of Neurology, S.Orsola- Malpighi Hospital, University of Bologna, Bologna, Italy. Research supported by Ministero Università e Ricerca Scientifica e Tecnologica of Italy, Grant ex 40%, 1996. Manuscript received March 28, 2000; revision accepted December 13, 2000. Correspondence to: Fabio Cirignotta, MD, Sleep Medicine Unit, Unit of Neurology, S.Orsola-Malpighi Hospital, via Albertoni 15, 40138 Bologna, Italy; e-mail: cirignotta@orsola-malpighi.med.unibo.it recording of the same variables as standard polysomnography. Level III or modified portable sleep apnea testing is the unattended off-site monitoring of a minimum of four cardiorespiratory variables. Level IV or continuous single-bioparameter or dual-bioparameter recording is the unattended monitoring of one or two cardiorespiratory variables. Levels III and IV do not allow for sleep scoring. According the ASDA practice parameters, level II and III portable recordings are considered alternatives to standard laboratory polysomnography for the diagnosis of OSAS only in the following situations: (1) for patients with severe clinical symptoms indicating OSAS, when standard laboratory polysomnography is not readily available; (2) for patients who cannot be studied in the sleep laboratory; and (3) for follow-up studies to evaluate response to therapy. 2 Despite these restrictive guidelines, ambulatory systems have been widely used because they are less CHEST / 119 / 5/ MAY, 2001 1387

expensive than standard polysomnography and shorten the long waiting list of the sleep laboratory. MESAM 4 (MAP; Martinsried, Germany) is a computerized ambulatory cardiorespiratory monitor that records four parameters: breathing sound, heart rate, arterial oxygen saturation (Sao 2 ), and body position. 3 It is not a classic level III system because it does not measure respiratory effort that can be indirectly detected on the basis of other breathing variables. The device automatically processes the data calculating several respiratory and cardiac indexes indicative of obstructive apneas/hypopneas: intermittent snoring index (the number of pauses in snoring lasting 11 to 60 s/h), heart rate variation index (the number of sudden increases in heart rate from the baseline per hour), and oxygen desaturation index (ODI; the number of desaturation events equal or 4%/h). The device allows visual scoring of recording in full disclosure mode that presents on the screen and prints data in 10-min epochs. A few validation studies have been performed on the ME- SAM 4 device with conflicting results. Stoohs and Guilleminault 4 tested the reliability of the machine to identify patients with OSAS defined as a respiratory disorder index (RDI) 10, and found that the ODI had a specificity of 97% and a sensitivity of 92%; thus, the ODI could be used for diagnosis of OSAS. The other indexes (heart rate variation index and intermittent snoring index) were much less specific and sensitive, and not useful for diagnosis. 4 Other studies of the MESAM 4 device have found lower values of specificity and sensitivity for ODI, suggesting moreover that hand scoring is better than automatic scoring in the diagnosis of patients with a clinical suspicion of OSAS. 5,6 According to ASDA guidelines, we studied the MESAM 4 device in four patients with severe clinical symptoms indicating OSAS who could not wait for laboratory polysomnography. In a subgroup of these patients, we observed a significant discrepancy between automatically calculated ODI and a visual analysis of these recordings. This group included only patients classified as having OSAS stage III according to Lugaresi et al 7 or patients with overlap syndrome (OSAS plus COPD) or other types of sleep hypoxemia associated with upperairway obstruction (for example, obese subjects). 8 We called these cases complicated OSAS. We therefore compared visual and automatic scoring of ODI in a group of patients with complicated OSAS to account for this discrepancy. Materials and Methods We analyzed MESAM 4 recordings of 10 patients with complicated OSAS (4 women and 6 men; mean age, 45.8 years). We classified patients as having complicated OSAS if they presented with sleep periods 3 min in which rapid drops in Sao 2 related to apneas were superimposed on a progressive and sustained fall in baseline Sao 2 (Fig 1). The fall in baseline Sao 2 could appear immediately after falling asleep, lasting part of the sleep time, or could be present for short periods during the night, possibly related to rapid eye movement sleep. All patients underwent a nocturnal recording with MESAM 4 for diagnosis of OSAS. The instrument was applied by a sleep technician in the laboratory 4 h before programmed starting of night recording at home. All standard MESAM 4 parameters (breathing sounds, heart rate, Sao 2, body position) were monitored. In particular, oxygen saturation was monitored by a pulse oximeter with a sampling rate of 0.5/s. The sleep period to be analyzed for calculation of MESAM indexes was determined by the patient s sleep log and indicated in the computer-based scoring system of the device. Each MESAM 4 recording was scored blindly by two readers trained in polysomnographic interpretation. One scorer performed visual analysis of the recording on the printout of the full-disclosure mode in 10-min epochs. He analyzed the same sleep period automatically scored by the machine on the basis of sleep log. The desaturation events were visually identified by the following criteria: fall in Sao 2 4% compared with the previous value and a subsequent rise in Sao 2 of at least 4%, with maximum duration of the event of 2 min. The visual ODI was calculated dividing the total number of events identified by the scorer by the hours of the analyzed period. Since the events automatically scored are underlined, visual analysis was performed before automatic analysis. Another reader edited the automatic analysis. The ODI automatically calculated by the MESAM 4 device was obtained by dividing the total number of desaturation events recorded by the hours of the analyzed period. The system scores a desaturation event when Sao 2 falls 4% from baseline; the event lasts until 95% of baseline has been reached again. The maximum possible duration of the event is 2 min, while a desaturation 2 min is not scored as an event. Baseline saturation is calculated with an algorithm on the basis of the two highest values in the last 40 s. The two scorers were instructed to read recordings blindly as part of a study on reliability of MESAM 4 automatic calculation of the ODI in OSAS patients, independently from their severity. The differences between visual and automatic scoring of the ODI were analyzed by paired t test and by the Bland-Altman procedure. Results In our group of patients with complicated OSAS who were studied with the MESAM 4 device, the ODIs automatically calculated were significantly underestimated with respect to the visual ODIs (mean ODI, 43.5 vs 75.1; p 0.003). This difference was found in all patients; in some it was slight, while in others it was pronounced and could bias clinical judgment on OSAS severity. In particular, automatic ODI was in the range of mild-to-moderate OSAS in patients 1, 2, and 8, while visual scoring demonstrated very severe syndromes. Patient 7 also showed a marked difference (the visual ODI was twice the automatic score) even in the same range of severity. The difference between automatically scored ODI and visually scored ODI increased with the longer the sleep time with fall in Sao 2 baseline. These 1388 Clinical Investigations

Figure 1. MESAM 4 recording of a patient with complicated OSAS. Four parameters are recorded: breathing sound (Snor), heart rate (HR), Sao 2, and body position (Pos). SX left side; SC back; ER standing up; DX rightside; AD prone. In prolonged periods of the night, desaturation events are superimposed to a fall in baseline Sao 2. In this recording, the automatically calculated ODI was 38 and the visually calculated ODI was 81. periods represented 34% of total sleep time as a mean, ranging between 5% and 79% (Table 1). Bland-Altman comparison of data indicated wide differences between methods of analysis (Fig 2). The fall in Sao 2 baseline occurred independently of body position. The difference between manual and automatic analysis is due to the fact that the system does not score the desaturation events superimposed on a fall in baseline Sao 2, when this fall appears after the start of the automatic analysis (Fig 3). This failure depends on the algorithm by which the device recognizes a desaturation event and calculates the baseline. In fact, the software identifies the beginning of an event as a drop in Sao 2 of 4%, and the end of an event as the point when Sao 2 returns to 95% of baseline; the return to baseline should occur within 2 min from the start; both components are necessary for an event to be scored automatically. In complicated OSAS, 95% of baseline Sao 2 is not always reached again with resumption of breathing, so the event cannot be terminated and is not identified by the MESAM 4 device. The second error in the MESAM 4 algorithm is due to a software defect in calculating baseline Sao 2. The machine calculates the baseline at the time set by the scorer as start time of the automatic analysis. After this point if the Sao 2 drops by at least 4% and then fails to return to 95% of baseline values (ie, if the program identifies the start of the event, but not its end), the system does not calculate a new baseline value, missing the scoring of superimposed desaturation events. This occurs independently of the rate CHEST / 119 / 5/ MAY, 2001 1389

Table 1 Oxygen Desaturation Events and ODI in 10 Patients With Complicated OSAS: Comparison Between Hand Scoring and Automatic Analysis* Patients Variables 1 2 3 4 5 6 7 8 9 10 Mean Age, yr 36 56 48 42 31 40 38 29 63 75 45.8 Sex F F M M M M F M M F No. of events Hand scoring 619 717 698 398 291 645 657 597 571 419 561 Automatic analysis 160 107 569 286 237 490 313 186 539 280 317 ODI Hand scoring 88 80 76 61 56 117 81 75 63 52 75.1 Automatic analysis 23 12 63 44 46 92 38 22 59 35 43.5 Percentage of time with software failure 54 79 3 31 12 6 43 53 5 39 34 *M male; F female. Paired t test for hand scoring vs automatic analysis 0.004. Paired t test for hand scoring vs automatic analysis 0.003. Percentage of sleep time spent with Sao 2 below baseline calculated at the beginning of the analysis. and degree of decline of the baseline Sao 2. There appears to be no time limit beyond which the machine recalculates a new baseline if the Sao 2 value fails to return to the original baseline. If we set the start time of the automatic analysis at a different recording point, when baseline was already lowered, a new baseline was calculated and, as long as it remains stable, the events previously unrecognized were automatically identified (Fig 4). However, we found a good correlation between visual and automatic scoring of the ODI when we considered series of desaturation events with return to baseline Sao 2 at the end of each event. We compared visually and automatically analyzed samples of tracings of all patients showing a series of desaturation events with a return to baseline Sao 2 at the end of each event, for a total of 5 h and 39 min of recording time. In this instance, visual and automatic calculation of the ODI showed no significant differences (automatic ODI of 82.3 vs visual ODI of 86.4; not significant). Discussion Our study demonstrates that ODI automatic analysis performed by the MESAM 4 device is not reliable when baseline Sao 2 levels drop during re- Figure 2. Bland-Altman plot of difference (diff) against mean for ODI data. 1390 Clinical Investigations

Figure 3. MESAM 4 recording of the same patient as described in Figure 1, in standard (top) and full-disclosure mode. In full-disclosure mode, the desaturation events automatically detected are underlined by the device. The analysis begun at 11:10 pm (23 10) (arrow). The system initially scored the events. As soon as the baseline Sao 2 dropped at 11:16 pm (23 16), the system no longer identified the events, which were visually clearly detectable, as long as Sao 2 did not return to baseline levels (11:43 pm [23 43]). The recorded parameters and abbreviations are described in Figure 1. cordings. This usually happens in patients with complicated OSAS (as described in the introduction) whose severe clinical condition and need for urgent treatment justifies an unattended sleep study, according the ASDA guidelines. In these patients, the clinical judgment on the severity of OSAS and the following therapeutic decisions could be seriously misled if based on automatic ODI alone. Some discrepancies between automatic and manual calculation of ODI have been mentioned in previous articles but were not systematically analyzed. In their validation study, Stoohs and Guilleminault 4 described three patients who presented major differences in the RDI calculated by polysomnography and the ODI calculated by the MESAM 4 device (RDIs of 83.5, 84.9, and 88.9 vs ODIs of 40, 38, and 51, respectively). The discrepancies were ascribed to the difference in the total sleep time and total analysis time calculation and to the fact that some events did not lead to Sao 2 drops of 3%. 4 Given our findings, we wonder whether these discrepancies could have been due to a fall in baseline Sao 2 during sleep. Moreover, Koziej et al 5 and Esnaola et al 6 showed that visual scoring of MESAM 4 tracings is more reliable than automatic scoring in screening OSAS patients, but they did not look for different results depending on the severity of OSAS. Our study emphasizes the ASDA recommendation CHEST / 119 / 5/ MAY, 2001 1391

Figure 4. MESAM 4 recording in full-disclosure mode showing the same sleep period twice. Top: the analysis starts before the lowering of baseline Sao 2 (arrow) and desaturation events are not recognized. Bottom: the analysis starts after the lowering of baseline Sao 2 and desaturation events previously unrecognized are identified (underlined). The recorded parameters and abbreviations are described in Figure 1. on the use of portable systems in the assessment of OSAS stating that computer analysis of recording data are acceptable only if used as an aid to interpretation in conjunction with visual inspection of the entire raw data report. 2 In fact, our results indicated that hand calculation of ODI on MESAM 4 recordings is necessary when studying a patient with complicated OSAS whose oximetry tracing shows falls in baseline Sao 2 associated with desaturation events related to apneas. However, we did not find significant differences between manual and automatic scoring of ODI when we considered samples of tracing with desaturation events characterized by a return to baseline values; this seems to suggest that the MESAM 4 automatic analysis could be reliable in the diagnosis of severe OSAS in patients without associated pathologic conditions. In conclusion, our study suggests that although the MESAM 4 system can be useful for studying OSAS patients with severe clinical symptoms who need urgent sleep study in order to start treatment, the indexes obtained automatically should always be compared with visual evaluation of all-night recordings performed by personnel trained in polysomnography. References 1 ASDA Standards of Practice Committee. Portable recording in the assessment of obstructive sleep apnea. Sleep 1994; 17:378 392 2 ASDA Standards of Practice Committee. Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea. Sleep 1994; 17:372 377 3 Penzel T, Althaus W, Meinzer K, et al. A device for ambulatory heart rate, oxygen saturation and snoring recording: 13th Annual International Conference IEEE EMBS. New Front Biomed Eng 1991; 13:1616 1617 4 Stoohs R, Guilleminault C. MESAM 4: an ambulatory device for the detection of patients at risk for obstructive sleep apnea syndrome (OSAS). Chest 1992; 101:1221 1227 5 Koziej M, Cieslicki JK, Gorzelak K, et al. Hand-scoring of MESAM 4 recordings is more accurate than automatic analysis in screening for obstructive sleep apnea. Eur Respir J 1994; 7:1771 1775 6 Esnaola S, Duran J, Infante-Rivard C, et al. Diagnostic accuracy of a portable recording device (MESAM 4) in suspected obstructive sleep apnoea. Eur Respir J 1996; 9:2597 2605 7 Lugaresi E, Mondini S, Zucconi M, et al. Staging of heavy snorers disease: a proposal. Bull Eur Physiopathol Respir 1983; 19:590 594 8 Flenley DC. Chronic obstructive pulmonary disease. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia, PA: WB Saunders, 1989; 601 611 1392 Clinical Investigations